Drug recall · July 17, 2013
Amikacin Sulfate 250 mg/ml Injection recall
Why: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amikacin Sulfate 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
- Lots / codes
B5501 Exp 8/5/13 and B3025 Exp 12/31/13
- Quantity
- 2
- Company
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy, Orlando, FL
- Distribution
- Nationwide and PR
- Initiated
- May 29, 2013 · Voluntary: Firm initiated
- Classified
- July 11, 2013
- Reported
- July 17, 2013
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amikacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.